Доступ предоставлен для: Guest
Critical Reviews™ in Immunology

Выходит 6 номеров в год

ISSN Печать: 1040-8401

ISSN Онлайн: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Induction of Dendritic Cells (DC) by Flt3 Ligand (FL) Promotes the Generation of Tumor-Specific Immune Responses In Vivo

Том 18, Выпуск 1-2, 1998, pp. 99-107
DOI: 10.1615/CritRevImmunol.v18.i1-2.110
Get accessGet access

Краткое описание

Daily treatment of mice with human Flt3 ligand (FL) induces the production of large numbers of ÌÍÑ-class II+, CDllc+, DEC205+ dendritic cells (DC) in both lymphoid and nonlymphoid tissues. Because DC play a pivotal role in the induction of immune responses, we evaluated the effects of FL in the augmentation of anti-tumor immune responses in vivo. Treatment with daily subcutaneous injections of FL not only caused complete regression of tumors in a significant proportion of mice challenged with a syngeneic methylcholanthrene-induced fibrosarcoma, but also caused a significant decrease in the tumor growth rate in the remaining mice. The effects of FL were both dose and schedule dependent, induced regression of tumors established as much as 7 days prior to beginning cytokine treatment, and was mediated by both T-cell-mediated and non-T-cell-mediated mechanisms. Histopathologic evaluation of tumors during and after systemic treatment with FL revealed a dense infiltration of mononuclear and myeloid precursor cells into both the tumor and tissue surrounding the tumor that generally correlated with the degree of regression and resolved after rejection of the tumor. Collectively, the data suggest that FL may be an important cytokine in the generation of effective anti-tumor immune responses in vivo and the treatment of cancer in situ.

Ключевые слова: cancer, immunotherapy, tumor immunity.
ЦИТИРОВАНО В
  1. Disis Mary L, Schiffman Kathy, Salazar Lupe G, Almand Bond, Knutson Keith L, , 21, 2003. Crossref

  2. Shurin Michael R., Yurkovetsky Zoya R., Tourkova Irina L., Balkir Levent, Shurin Galina V., Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10, International Journal of Cancer, 101, 1, 2002. Crossref

  3. Chen Wangxue, Rains Natalie, Young David, Stubbs Richard S, Dendritic cell‐based cancer immunotherapy: Potential for treatment of colorectal cancer?, Journal of Gastroenterology and Hepatology, 15, 7, 2000. Crossref

  4. Byrne Scott N, Halliday Gary M, Dendritic cells: Making progress with tumour regression?, Immunology and Cell Biology, 80, 6, 2002. Crossref

  5. Talmadge James E., Biotherapeutics, in Biotechnology and Safety Assessment, 2003. Crossref

  6. Tourkova Irina L., Yamabe Kazuo, Chatta Gurkamal, Shurin Galina V., Shurin Michael R., NK Cells Mediate Flt3 Ligand-Induced Protection of Dendritic Cell Precursors In Vivo from the Inhibition by Prostate Carcinoma in the Murine Bone Marrow Metastasis Model, Journal of Immunotherapy, 26, 6, 2003. Crossref

  7. Jones Lori A, Salgaller Michael L, Therapeutic potential of dendritic-based vaccines, Expert Opinion on Investigational Drugs, 8, 7, 1999. Crossref

  8. Le Poole I. Caroline, ElMasri Wafic M., Denman Cecele J., Kroll Tara M., Bommiasamy Hemamalini, Lyons Eiben Gretchen, Kast W. Martin, Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells, Cancer Immunology, Immunotherapy, 57, 6, 2008. Crossref

  9. Kreitman Robert J, IBC’s International Conference on Novel Therapeutic Proteins for Oncology (Drug Discovery and Development), Expert Opinion on Investigational Drugs, 7, 4, 1998. Crossref

  10. Shurin Galina V, Chatta Gurkamal S, Tourkova Irina L, Zorina Tatiana D, Esche Clemens, Shurin Michael R, Regulation of dendritic cell expansion in aged athymic nude mice by FLT3 ligand, Experimental Gerontology, 39, 3, 2004. Crossref

  11. Baek Kyoung Min, Ko Sung-Youl, Lee Mira, Lee Joong-Seok, Kim Jae-Ouk, Ko Hyun-Jeong, Lee Jae-Woo, Lee Sang-Hoon, Cho Sang-Nae, Kang Chang-Yuil, Comparative analysis of effects of cytokine gene adjuvants on DNA vaccination against Mycobacterium tuberculosis heat shock protein 65, Vaccine, 21, 25-26, 2003. Crossref

  12. Dallal Ramsey M, Lotze Michael T, The dendritic cell and human cancer vaccines, Current Opinion in Immunology, 12, 5, 2000. Crossref

  13. Smyth Mark J., Thia Kevin Y. T., Street Shayna E.A., Cretney Erika, Trapani Joseph A., Taniguchi Masaru, Kawano Tetsu, Pelikan Sonja B., Crowe Nadine Y., Godfrey Dale I., Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells, Journal of Experimental Medicine, 191, 4, 2000. Crossref

  14. Venanzi F.M., Barucca A., Havas K., Capitani M., Provinciali M., Scotti S., Concetti A., Co-expression of Flt-3 ligand gene ablates tumor immunity elicited by HER-2/neu DNA vaccine in transgenic mice, Vaccine, 28, 22, 2010. Crossref

  15. Aloysius M.M., Takhar A., Robins A., Eremin O., Dendritic cell biology, dysfunction and immunotherapy in gastrointestinal cancers, The Surgeon, 4, 4, 2006. Crossref

  16. Pisarev Vladimir M, Parajuli Prahlad, Mosley R.Lee, Sublet Jennifer, Kelsey Linda, Sarin Prem S, Zimmerman Daniel H, Winship M.Douglas, Talmadge James E, Flt3 ligand enhances the immunogenicity of a gag-based HIV-1 vaccine, International Journal of Immunopharmacology, 22, 11, 2000. Crossref

  17. Morse Michael A., Immunotherapy for Resected Pulmonary Metastases, Thoracic Surgery Clinics, 26, 1, 2016. Crossref

  18. Kwon Taeg Kyu, Park Jong-Wook, Intramuscular co-injection of naked DNA encoding HBV core antigen and Flt3 ligand suppresses anti-HBc antibody response, Immunology Letters, 81, 3, 2002. Crossref

  19. Xing Feiyue, Wang Jiongkun, Fang Zhiyuan, Hu Mingqian, Yu Yu, Chen Guoliang, Liu Jing, Nano-characterization of Jagged-1-educated dendritic cells, Open Life Sciences, 6, 6, 2011. Crossref

  20. Evans Thomas G, Hasan Muhammad, Galibert Laurent, Caron Dania, The use of Flt3 ligand as an adjuvant for hepatitis B vaccination of healthy adults, Vaccine, 21, 3-4, 2002. Crossref

  21. Brown Janice M, Weissman Irving L, Shizuru Judith A, Immunity to infections following hematopoietic cell transplantation, Current Opinion in Immunology, 13, 4, 2001. Crossref

  22. Rini Brian, Recent clinical development of dendritic cell-based immunotherapy for prostate cancer, Expert Opinion on Biological Therapy, 4, 11, 2004. Crossref

  23. Kim Eugene M., Sivanandham Muthukumaran, Stavropoulos Christos I., Wallack Marc K., Adjuvant Effect of a Flt3 Ligand (FL) Gene-Transduced Xenogeneic Cell Line in a Murine Colon Cancer Model, Journal of Surgical Research, 108, 1, 2002. Crossref

  24. Panoskaltsis Nicki, Belanger Todd J, Liesveld Jane L, Abboud Camille N, Optimal cytokine stimulation for the enhanced generation of leukemic dendritic cells in short-term culture, Leukemia Research, 26, 2, 2002. Crossref

  25. Lee Mosley R, Parajuli Prahlad, Pisarev Vladimir, Chavez Jennifer, Meeks Amy, Steffel Amy, Leutzinger Cheryl, Talmadge James E, Flt3 ligand augmentation of T cell mitogenesis and expansion of type 1 effector/memory T cells, International Immunopharmacology, 2, 7, 2002. Crossref

  26. D'Amico Angela , Wu Li , The Early Progenitors of Mouse Dendritic Cells and Plasmacytoid Predendritic Cells Are within the Bone Marrow Hemopoietic Precursors Expressing Flt3 , Journal of Experimental Medicine, 198, 2, 2003. Crossref

  27. Ali Sumia, Curtin James F., Zirger Jeffrey M., Xiong Weidong, King Gwendalyn D., Barcia Carlos, Liu Chunyan, Puntel Mariana, Goverdhana Shyam, Lowenstein Pedro R., Castro Maria G., Inflammatory and Anti-glioma Effects of an Adenovirus Expressing Human Soluble Fms-like Tyrosine Kinase 3 Ligand (hsFlt3L): Treatment with hsFlt3L Inhibits Intracranial Glioma Progression, Molecular Therapy, 10, 6, 2004. Crossref

  28. Favre-Felix Nathalie, Martin Monique, Maraskovsky Eugene, Fromentin Annie, Moutet Monique, Solary Eric, Martin Fran�ois, Bonnotte Bernard, Flt3 ligand lessens the growth of tumors obtained after colon cancer cell injection in rats but does not restore tumor-suppressed dendritic cell function, International Journal of Cancer, 86, 6, 2000. Crossref

  29. Cui Yan, Kelleher Erin, Straley Erin, Fuchs Ephraim, Gorski Kevin, Levitsky Hyam, Borrello Ivan, Civin Curt I, Schoenberger Stephen P, Cheng Linzhao, Pardoll Drew M, Whartenby Katharine A, Immunotherapy of established tumors using bone marrow transplantation with antigen gene–modified hematopoietic stem cells, Nature Medicine, 9, 7, 2003. Crossref

  30. Weigel Brenda J., Nath Narender, Taylor Patricia A., Panoskaltsis-Mortari Angela, Chen Wei, Krieg Arthur M., Brasel Kenneth, Blazar Bruce R., Comparative analysis of murine marrow–derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses, Blood, 100, 12, 2002. Crossref

  31. Xing Feiyue, Wang Jiongkun, Hu Mingqian, Yu Yu, Chen Guoliang, Liu Jing, Comparison of immature and mature bone marrow-derived dendritic cells by atomic force microscopy, Nanoscale Research Letters, 6, 1, 2011. Crossref

  32. Pawlowska Anna B., Hashino Satoshi, McKenna Hilary, Weigel Brenda J., Taylor Patricia A., Blazar Bruce R., In vitro tumor-pulsed or in vivo Flt3 ligand–generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow–transplanted mice, Blood, 97, 5, 2001. Crossref

  33. O'Keeffe Meredith, Hochrein Hubertus, Vremec David, Pooley Joanne, Evans Robert, Woulfe Susan, Shortman Ken, Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice, Blood, 99, 6, 2002. Crossref

  34. Disis Mary L., Rinn Kristine, Knutson Keith L., Davis Donna, Caron Dania, dela Rosa Corazon, Schiffman Kathy, Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu–overexpressing cancers, Blood, 99, 8, 2002. Crossref

  35. Alaniz Robert C., Sandall Sharsti, Thomas Elaine K., Wilson Christopher B., Increased Dendritic Cell Numbers Impair Protective Immunity to Intracellular Bacteria Despite Augmenting Antigen-Specific CD8+T Lymphocyte Responses, The Journal of Immunology, 172, 6, 2004. Crossref

  36. Wang Jing-Bo, Huang Xue, Li Fu-Rong, Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives, Cancer Communications, 39, 1, 2019. Crossref

  37. Ho Ling-Jun, Wang Jaang-Jiun, Shaio Men-Fang, Kao Chuan-Liang, Chang Deh-Ming, Han Shou-Wha, Lai Jenn-Haung, Infection of Human Dendritic Cells by Dengue Virus Causes Cell Maturation and Cytokine Production, The Journal of Immunology, 166, 3, 2001. Crossref

  38. Moore Anne C., Kong Wing-pui, Chakrabarti Bimal K., Nabel Gary J., Effects of Antigen and Genetic Adjuvants on Immune Responses to Human Immunodeficiency Virus DNA Vaccines in Mice, Journal of Virology, 76, 1, 2002. Crossref

  39. Whartenby Katharine A., Calabresi Peter A., McCadden Erin, Nguyen Bao, Kardian David, Wang Tianhong, Mosse Claudio, Pardoll Drew M., Small Donald, Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease, Proceedings of the National Academy of Sciences, 102, 46, 2005. Crossref

  40. Morse Michael A., Nair Smita, Fernandez-Casal Monica, Deng Yuping, St Peter Michelle, Williams Rhonda, Hobeika Amy, Mosca Paul, Clay Tim, Cumming R. Ian, Fisher Eva, Clavien Pierre, Proia Alan D., Niedzwiecki Donna, Caron Dania, Lyerly H. Kim, Preoperative Mobilization of Circulating Dendritic Cells by Flt3 Ligand Administration to Patients With Metastatic Colon Cancer, Journal of Clinical Oncology, 18, 23, 2000. Crossref

  41. Parajuli Prahlad, Mosley R.Lee, Pisarev Vladimir, Chavez Jennifer, Ulrich Amy, Varney Michelle, Singh Rakesh K, Talmadge James E, Flt3 ligand and granulocyte-macrophage colony-stimulating factor preferentially expand and stimulate different dendritic and T-cell subsets, Experimental Hematology, 29, 10, 2001. Crossref

  42. Péron Jean-Marie, Esche Clemens, Subbotin Vladimir M., Maliszewski Charles, Lotze Michael T., Shurin Michael R., FLT3-Ligand Administration Inhibits Liver Metastases: Role of NK Cells, The Journal of Immunology, 161, 11, 1998. Crossref

  43. Williams Noelle Sevilir, Klem Jennifer, Puzanov Igor J., Sivakumar P. V., Bennett Michael, Kumar Vinay, Differentiation of NK1.1+, Ly49+ NK Cells from flt3+ Multipotent Marrow Progenitor Cells, The Journal of Immunology, 163, 5, 1999. Crossref

Статьи, принятые к публикации

Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effect of p-estrogen receptor at serine on its function and breast growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang MiRNA let-7d-5p alleviates inflammatory responses by targeting Map3k1 and inactivating ERK/p38 MAPK signaling in microglia Fan Fang, Cheng Chen Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro Kawaljit Kaur, Anahid Jewett The Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven Raman, Anahid Jewett, Jason Chiang Phillygenin alleviated arthritis through the inhibition of NLRP3 inflammasome and Ferroptosis by AMPK Jianghui Wang, Shufang Ni, Kai Zheng, Yan Zhao, peihong zhang, Hong Chang The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis Hao Zhou Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain Serum interleukin 6 and ferritin levels are the independent risk factors for pneumonia in elderly patients Hao Yuan, Jing Tian, Lu Wen Exploration of diagnostic markers associated with inflammation in chronic kidney disease (CKD) based on WGCNA and machine learning Qianjia Wu, Yang Yang, Chongze Lin Clinical significance of serum CTRP3 level in the prediction of cardiac dysfunction and intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis Qiang Shao, Lin Sun The protective effect and mechanism of mild hypothermia on pig lung injury after cardiopulmonary resuscitation Jinlin Ren, Fangfang Zhu, Dongdong Sang, Mulin Cong, Shujuan Jiang Exploring mechanism of Zilongjin in treating lung adenocarcinoma based on network pharmacology combined with experimental verification Kang Zhang, Xiaoqun Chen Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Genes Analysis Jian Shen, Minzhe Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei Identification of key ubiquitination-related genes and their associated with immune infiltration in osteoarthritis based on mRNA-miRNA network Dalu Yuan, Hailiang Shen, Lina Bai, Menglin Li, Qiujie Ye Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia Yan Li, Jing Zhang, Suhang Wang, Jie Cao Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma Rongjin Zhou, Junguo Wang Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2 Fei Li, Ying-pei Ling, Pan Wang, Shi-cheng Gu, Hao Jiang, Jie Zhu
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain